Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
React to this article
Latest news on BAYER AG
04/17 BAYER CROPSCIENCE : 100 young leaders from across the globe to meet in Australia..
04/17 BAYER : to early redeem EUR 1.3 billion bond issued in 2005
04/15 BAYER : to early redeem EUR 1.3 billion bond issued in 2005
04/14 BAYER : MaterialScience at UTECH 2015 -- Focus on a circular economy -- Committe..
04/14 BAYER : MaterialScience driving forward the use of carbon dioxide -- CO2 - a con..
04/14 BAYER : Companion Vector-Borne Diseases Web Conference Advances 'One Health' App..
04/14 BAYER : Aktiengesellschaft: Release according to Article 26, Section 1 of the Wp..
04/13 BAYER : CropScience and Farm Frites jointly implement sustainable practices in E..
04/12 BAYER CROPSCIENCE : Garners $100K to North Carolina Roadside Pollinator Planting..
04/10DJCan Owens-Illinois Find New Growth in Glass Bottles?
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes